Dr Anthony Cunliffe outlines the new service specifications for primary care networks, and explains how they will facilitate earlier diagnosis of cancer

Photo of Dr Anthony Cunliffe

Dr Anthony Cunliffe

Read this article to learn more about:

  • the ambitions of the NHS long term plan around early diagnosis of cancer
  • the impact of the COVID-19 pandemic on cancer diagnosis and treatment
  • how to implement the primary care network service specification on early cancer diagnosis.

Implementation actions for STPs and ICSs

Read this article online at: GinP.co.uk/456380.article

In the 2019 NHS long term plan, NHS England set out its ambition to ensure that, by 2028, 75% of people with cancer will be diagnosed at an early stage.1 In the UK, the majority of people who are subsequently diagnosed with cancer first present with symptoms or concerns to their primary care teams; therefore, as primary care physicians, we have an essential role in ensuring that people are diagnosed as early and as quickly as possible.2–6

However, this is challenging for GPs—every day, we consult with people who present with symptoms that may represent an underlying cancer. In the majority of these referrals, the person will not be diagnosed with cancer, and each full-time GP may only diagnose around six to eight people with cancer each year.7 This means that GPs have the very difficult job of identifying those patients whose symptoms need urgent investigation—while not sending patients for unnecessary tests, which cause undue worry and add to pressure on the health system. As you can imagine, this is not an easy task.

The impact of COVID-19

The situation has been made even more exacting by the COVID-19 pandemic, which has affected the early diagnosis of cancer in several ways. Initially, we saw a significant negative impact on the number of people being referred via an urgent suspected cancer (USC) pathway, meaning that many people who would normally be investigated and either diagnosed or reassured were not entering the system.8 This may have been because they were reluctant to present to a health environment that they weren’t confident was safe, or due to concerns about overburdening the health service, or because changes to screening services and diagnostic pathways were impacting their ability to be seen.8,9

Although most of the USC pathways have now recovered to above pre-pandemic referral levels, some are still lagging behind. In addition, there remains a large backlog of patients awaiting diagnosis and treatment, as well as patients who have not yet entered the system.9–11 In its report The forgotten C? The impact of COVID-19 on cancer care  Macmillan Cancer Support estimates that 50,000 people are now missing a cancer diagnosis.12 Another significant change during the pandemic was the move to virtual consultations. This switch brought with it a new challenge for primary care physicians, who had to ensure that the right people were still being identified for further investigation, even those whose initial contact had been virtual.

We could continue to talk about the difficulties of diagnosing cancer earlier and the likely negative effect that the COVID-19 pandemic has had on this, and about the significant progress towards diagnosing cancer earlier that has been made in recent years. However, what we need to focus on now is what we can do, as primary care teams, to contribute to the recovery of the health system and return to progressing towards the ambitions of the NHS long term plan.1

The Primary Care Network Directed Enhanced Service

The development of primary care networks (PCNs) brought with it the introduction of the Primary Care Network Directed Enhanced Service (DES);13 the first service requirement, covering the early diagnosis of cancer, was introduced just before the start of the pandemic.14 There was a delay in the initial implementation of this service requirement, for obvious reasons, but it is one of only four of the original requirements of the PCN DES that PCNs are expected to have commenced and be progressing with.15 The early diagnosis of cancer service specification for 2021–2022 consists of three main elements (see Box 1).

Box 1: Elements of the early diagnosis of cancer service specification for 2021–202214

  • Review referral practice for suspected cancers, including recurrent cancers. To fulfil this requirement, a PCN must:
    • review the quality of the PCN’s core network practices’ referrals for suspected cancer against the recommendations of NICE Guideline 12,[A] and make use of:
      • clinical decision-support tools
      • practice-level data to explore local patterns in presentation and diagnosis of cancer; and
      • where available, the Rapid Diagnostic Centre pathway for people with serious but nonspecific symptoms
    • build on current practice to ensure a robust and consistent approach to monitoring patients who have been referred urgently with suspected cancer or for further investigations to exclude the possibility of cancer (‘safety netting’), in line with NICE Guideline 12[A]
    • ensure that all patients are signposted to or receive information on their referral, including why they are being referred, the importance of attending appointments, and where they can access further support
    • in undertaking the above, identify and implement specific actions to address unwarranted variation and inequality in cancer outcomes, including access to relevant services
  • Contribute to improving local uptake of national cancer screening programmes. To fulfil this requirement, a PCN must:
    • work with local system partners—including the NHSEI Regional Public Health Commissioning Team and Cancer Alliance—to agree the PCN’s contribution to local improvement plans, which should build on any existing actions across the PCN’s core network practices. This must include at least one specific action to engage with a group with low participation locally, with agreed timescales
    • support the restoration of the NHS Cervical Screening Programme by identifying opportunities across a network to provide sufficient cervical screening sample-taking capacity
  • Establish a community of practice between practice-level clinical staff to support delivery of the requirements of the Network Contract DES Specification. To fulfil this requirement, a PCN must:
    • conduct peer-to-peer learning events that look at data and trends in diagnosis across the PCN, including cases where patients presented repeatedly before referral and late diagnoses
    • engage with local system partners, including patient participation groups, secondary care, the relevant cancer alliance, and public health commissioning teams
    • identify successful improvement activity undertaken by constituent practices in support of the 2020–2021 Quality and Outcomes Framework requirements on early cancer diagnosis. Ensure that successful practice is implemented and developed across the PCN.

[A] NICE. Suspected cancer: recognition and referral. NICE Guideline 12. NICE, 2015 (last updated 2021). Available at: www.nice.org.uk/ng12 

PCN=primary care network; NHSEI=NHS England and NHS Improvement; DES=Directed Enhanced Service

Contains public sector information licensed under the Open Government Licence v3.0.

Overlap with the Quality and Outcomes Framework

For this financial year, one of the quality improvement (QI) modules of the Quality and Outcomes Framework (QoF) is also focused on the early diagnosis of cancer.16,17 This has caused some confusion as to the differences and similarities between the QI module on early cancer diagnosis and the DES. Essentially, they both cover very similar themes, and any work done for the QoF will be very relevant to the requirements of the PCN service specification.

The QoF QI module is only 1 year long and is focused at practice level; however, it may be useful to consider how any work completed or started within practices as part of the QoF QI module on early cancer diangosis could be built upon or fed into the work planned at PCN level for the DES. It is a perfect opportunity to spread learning and best practice between practices that may lead to changes at PCN level over a longer period of time.

How will the service specification achieve earlier cancer diagnosis?

Reviewing referral practices for suspected cancer

A review of referral practices for suspected cancer is an element of both the QoF QI module on early cancer diagnosis and the PCN DES,14,16 highlighting how important it is to ensure that referrals for people on a USC pathway are of a high quality. The element requires organisations to have systems in place to review the quality of referral practices, so that continuous improvement can be made.

There are various aspects of referral quality that a practice or PCN may decide to review, and various processes through which this can be undertaken. These include:

  • education for practice teams on the criteria for USC referrals18
  • audits of routes to diagnosis for people who have received a cancer diagnosis16
  • learning event analysis19 of cases in which diagnosis was delayed.

Once practices or PCNs have decided what to focus on, various tools and resources are available to support them with their review (see Box 2).20,21

In addition, GatewayC—a free educational resource for primary care healthcare professionals in England—has a module called ‘Improving the quality of your referral’ that may help PCNs and practices with this part of the DES specification (see Box 2).22

Box 2: Tools and resources supporting implementation of the PCN DES on early cancer diagnosis

Reviewing and improving referral quality

  • Royal College of General Practitioners. Early diagnosis of cancer—significant event analysis toolkit: bit.ly/3i91JSo
  • Royal College of General Practitioners. Significant event analysis GP guide—early diagnosis of cancer: bit.ly/3AGmfkJ
  • GatewayC. Improve the quality of your referral with GatewayC: bit.ly/3EVzgJz

Safety netting

  • Macmillan Cancer Support. Safety netting in primary care consultations: bit.ly/3udrLJ8

Communication with patients

Improving screening uptake

  • Cancer Research UK. Early diagnosis of cancer: guide to the GP contract 2021/22 for primary care networks (PCNs) and practices: bit.ly/3kMHwUt

Implementing the PCN DES and QoF QI module on early cancer diagnosis

  • Macmillan Cancer Support. Resources for GPs. bit.ly/3zFobc1
  • Cancer Research UK. Early diagnosis of cancer: guide to the GP contract 2021/22 for primary care networks (PCNs) and practices: bit.ly/3kMHwUt

PCN=primary care network; DES=Directed Enhanced Service; QoF=Quality and Outcomes Framework; QI=quality improvement

Safety netting

Safety netting in primary care is another element that is covered in both the QoF QI module on early cancer diagnosis and the PCN DES.14,16 This emphasises the importance of having robust systems in place across primary care to confirm that people referred on a USC pathway or for an urgent test have been seen, and that people presenting to us with potentially concerning symptoms are followed up. Again, there are various tools and resources to support with this—including for integration into GP practice information technology systems—that can be found on the Macmillan Cancer Support website (see Box 2).23

It is an essential part of good practice to ensure that patients have a good understanding regarding any referrals that are made, so that they appreciate what to expect, are aware of any preparation they may need to do, and know what action to take if things don’t happen as anticipated. This communication is a fundamental part of safety netting; it should be delivered verbally as part of the consultation, but it can be augmented by the use of patient information leaflets, provided either as hard copy or digitally via text or email. Useful resources to help with this are available from both Macmillan Cancer Support24 and Cancer Research UK (CRUK; see Box 2).25

Improving local uptake of national cancer screening programmes

Increasing the uptake of national screening programmes is one of the most important ways in which primary care can contribute to the earlier diagnosis of cancer.26 Some areas of the country have very poor uptake of national cancer screening programmes—as low as 45.1% for bowel screening, 51.8% for breast screening, and 47.4% for cervical screening.27

Evidence shows that GP endorsement of screening programmes can lead to an increased uptake;28 therefore, practices and PCNs should be encouraged to review their screening data and look at ways in which they can encourage and assist people to participate in screening programmes. The decision to take part is down to the individual, but efforts to increase uptake can focus on ensuring that people who decline have first received the right information and had a chance to discuss their concerns.

It is important for PCNs and practices to understand their local data in order to decide where to focus their efforts when it comes to screening. One useful source is the Public Health England Fingertips database,27 which shows uptake at practice or PCN level relative to other local areas or national statistics. More information on how to improve screening uptake can be found in the CRUK PCN DES Hub (see Box 2).29

Establishing a community of practice to support delivery of the requirements

One of the benefits of working together as practices within a PCN is the sharing of best practice and resources, and this is the basis of the development of a ‘community of practice’. It is likely that much of the work required may already be happening at some level within PCNs, so getting together early to review progress may be very useful in agreeing any work plans. Where practices have already had success in some of these areas, sharing how they attained it and supporting other practices to do the same is fundamental to disseminating learning and success across a bigger footprint. If challenges arise, or there is uncertainty as to what to focus on, discussing this at PCN level with a range of interested primary care healthcare professionals may help to overcome barriers and enable the practices involved to agree on priorities. Having clinical and nonclinical champions to lead on the different requirements may make the work run more smoothly, and increase the chance of successful outcomes.

Tackling health inequalities

Health inequalities are defined as avoidable and unjust differences in health status between groups, populations, or individuals generated by social, environmental, and economic variation within societies.30 These differences can influence an individual’s risk of ill health, and affect their ability to access treatment.30 Addressing these inequalities should be a fundamental consideration in everything we do as healthcare practitioners.

The QI requirements outlined in the QoF QI module on early cancer diagnosis and PCN DES provide us with an opportunity to review the prominent inequalities affecting our local populations, enabling us to ensure that these are addressed as workplans are put into place.14,16

Working with local partners

Finally, although these contractual pieces of work are to be led by GPs at practice or PCN level, it is important that we work with other local partners and organisations, both to get any support available and to prevent duplication of work. All areas of England are covered by cancer alliances,31 and it is likely that all alliances have work planned to support PCNs in their area with the DES. Reach out to your local alliance and find out what support is available—this may include help with identifying the right data to inform your work, educational programmes and events, and direct support from cancer lead GPs. Another great source of help is the third sector: both Macmillan Cancer Support  and CRUK have created resources to help with the QoF QI module on early cancer diagnosis and the PCN DES (see Box 2).29,32

Summary

The world of general practice is busier than ever, and GPs may feel overburdened by having to deliver pieces of work like the ones discussed in this article. However, primary care teams are fundamental to the NHS’s plans to tackle late diagnosis of cancer. Take some time to review all of the good work that may be happening already, agree priorities, share good practice between practices and PCNs, and distribute the workload between team members.

Dr Anthony Cunliffe

Macmillan National Clinical Adviser for Primary Care, Macmillan Lead Clinical Adviser and Clinical Adviser for London and Joint Clinical Chair, South East London Cancer Alliance

Implementation actions for STPs and ICSs

written by Dr David Jenner, GP, Cullompton, Devon

The following implementation actions are designed to support STPs and ICSs with the challenges involved with implementing new guidance at a system level. Our aim is to help you consider how to deliver improvements to healthcare within the available resources.

  • Ensure that there is a local, multiprofessional cancer care team to identify and explore local variations in the incidence of cancer
  • Involve local public health departments to identify social and demographic profiles that may affect the incidence of cancer and uptake of cancer screening programmes
  • Facilitate local PCNs to work together to analyse these data and identify opportunities to increase earlier diagnosis
  • Audit new cancer diagnoses to learn from individual cases how earlier diagnosis could have been achieved
  • Examine whether the move towards virtual consultations during the pandemic is a help or a hindrance to earlier diagnosis of cancer
  • Coordinate these activities to ensure that they meet the requirements of the QoF and PCN DES and feed into local health improvement plans.

STP=sustainability and transformation partnership; ICS=integrated care system; PCN=primary care network; QoF=Quality and Outcomes Framework; DES=Directed Enhanced Service

References

  1. NHS England website. NHS long term plan ambitions for cancer. www.england.nhs.uk/cancer/strategy/ (accessed 27 September 2021).
  2. Hamilton W. Cancer diagnosis in primary care. BJGP 2010; 60 (571): 121–128.
  3. Hamilton W. Five misconceptions in cancer diagnosis. BJGP 2008; 2009; 59: 441–447.
  4. Barrett J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. BMC Fam Pract 2008; 9: 31.
  5. Barrett J, Hamilton W. Pathways to the diagnosis of prostate cancer in a British city. A population-based study. Scand J Urol Nephrol 2005; 39 (4): 267–270.
  6. Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract 2006; 23 (1): 15–19.
  7. Harker N. How GPs can offer cancer patients the support they need. www.gponline.com/gps-offer-cancer-patients-support-need/cancer/article/1441477 (accessed 27 September 2021).
  8. Richards M, Anderson M, Carter P et al. The impact of the COVID-19 pandemic on cancer care. Nat Cancer 2020; 1: 565–567.
  9. The Lancet Oncology. COVID-19 and cancer: 1 year on. Lancet Oncol  2021; 22 (4): 411.
  10. Cancer Research UK website. Our research into the impact of COVID-19 on cancer. www.cancerresearchuk.org/health-professional/our-research-into-the-impact-of-covid-19-on-cancer (accessed 30 September 2021).
  11. NHS Digital website. NHS e-referral service (e-RS) open data dashboard. digital.nhs.uk/dashboards/ers-open-data (accessed 30 September 2021).
  12. Macmillan Cancer Support. The forgotten ‘C’? The impact of Covid-19 on cancer care. London: Macmillan Cancer Support, 2020. Available at: www.macmillan.org.uk/assets/forgotten-c-impact-of-covid-19-on-cancer-care.pdf
  13. NHS Primary Care Group. Network contract directed enhanced service—guidance for 2021/2022 in England. London: NHS, 2021. Available at: www.england.nhs.uk/wp-content/uploads/2021/03/B0951-iv-network-contract-des-guidance-21-22-update.pdf  
  14. NHS Primary Care Group. Network contract directed enhanced service—early cancer diagnosis guidance. London: NHS, 2021. Available at: www.england.nhs.uk/wp-content/uploads/2021/03/B0431-network-contract-des-early-cancer-diagnosis-guidance-21-22.pdf
  15. NHS Primary Care Group. Network contract directed enhanced service. Contract specification 2021/22—PCN requirements and entitlements. London: NHS, 2021. Available at: www.england.nhs.uk/wp-content/uploads/2021/03/B0431-network-contract-des-specification-pcn-requirements-and-entitlements-21-22.pdf
  16. NHS England and NHS Improvement. QOF quality improvement domain 2020/21—early diagnosis of cancer. London: NHS England and NHS Improvement, 2021. Available at: www.england.nhs.uk/wp-content/uploads/2020/02/20-21-qof-qi-cancer.pdf
  17. British Medical Association General Practitioners Committee, NHS England. Quality and Outcomes Framework guidance for 2021/2022. London: NHS, 2021. Available at: www.england.nhs.uk/wp-content/uploads/2021/03/B0456-update-on-quality-outcomes-framework-changes-for-21-22-.pdf
  18. NICE. Suspected cancer: recognition and referral. NICE Guideline 12. NICE, 2015 (updated January 2021). Available at: www.nice.org.uk/ng12
  19. FourteenFish website. What is a learning event?support.fourteenfish.com/hc/en-gb/articles/360006895797-What-is-a-Learning-Event- (accessed 27 September 2021).
  20. Royal College of General Practitioners website. Early diagnosis of cancer significant event analysis toolkit. www.rcgp.org.uk/clinical-and-research/resources/toolkits/early-diagnosis-of-cancer-significant-event-analysis-toolkit.aspx (accessed 27 September 2021).
  21. Royal College of General Practitioners. Significant event analysis GP guide—early diagnosis of cancer. London: RCGP, 2016. Available at: gpexcellencegm.org.uk/wp-content/uploads/RGCP-GP-SEA-guide-280716b.pdf
  22. GatewayC website. Improve the quality of your referral with GatewayC. www.gatewayc.org.uk/all-blogs/improve-the-quality-of-your-referral/ (accessed 27 September 2021).
  23. Macmillan Cancer Suport website. Safety netting in primary care consultations. www.macmillan.org.uk/healthcare-professionals/cancer-pathways/prevention-and-diagnosis/safety-netting (accessed 27 September 2021).
  24. Macmillan Cancer Support website. Going for tests. www.macmillan.org.uk/cancer-information-and-support/diagnosis/going-for-tests (accessed 27 September 2021).
  25. Cancer Research UK. Your urgent referral explained. London: CRUK, 2020. Available at: publications.cancerresearchuk.org/sites/default/files/publication-files/UR01_TEXT_FINAL%20%283%29.pdf
  26. NHS England website. Screening and earlier diagnosis. www.england.nhs.uk/cancer/early-diagnosis/screening-and-earlier-diagnosis/ (accessed 27 September 2021).
  27. Public Health England website. Public health profiles. Cancer services. fingertips.phe.org.uk/profile/cancerservices (accessed 27 September 2021).
  28. Benton S, Butler P, Allen K et al. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. Br J Cancer 2017; 116 (12): 1551–1557.
  29. Cancer Research UK website. Early diagnosis of cancer: guide to the GP contract 2021/22 for primary care networks (PCNs) and practices. www.cancerresearchuk.org/health-professional/learning-and-support/resources/gp-contract-guide (accessed 27 September 2021).
  30. NHS England website. Reducing health inequalities resources. www.england.nhs.uk/about/equality/equality-hub/resources/ (accessed 27 September 2021).
  31. NHS England website. Cancer alliances—improving care locally. www.england.nhs.uk/cancer/cancer-alliances-improving-care-locally/ (accessed 27 September 2021).
  32. Macmillan Cancer Support website. Resources for GPs. www.macmillan.org.uk/healthcare-professionals/for-your-role/doctor/gp (accessed 27 September 2021).

Credit:

Lead image: Kateryna_Kon/stock.adobe.com

Topics